This inventor holds 3 USPTO granted patents. Top assignees: Snow Brand Milk Products Co., Ltd., Sumitomo Pharmaceuticals Company Limited, Toshikazu Nakamura and Sumitomo Pharmaceuticals Co., Ltd.. Active years: 1998-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2001
Title: Mitsuo Namiki: Innovator in Fibrosis Treatment
Introduction
Mitsuo Namiki is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of medical treatments, particularly in addressing fibrosis. With a total of 3 patents to his name, Namiki's work focuses on innovative methods to improve health outcomes.
Latest Patents
One of his latest patents is related to the treatment of fibrosis by Hepatocyte Growth Factors (HGFs). This invention outlines a method for treating fibrosis caused by excessive collagen deposition. The method involves administering HGFs, which accelerate the decomposition of collagen when given in an effective amount. Another significant patent he holds is for Peg-modified HGF, which further enhances the therapeutic potential of HGFs in treating various conditions.
Career Highlights
Throughout his career, Mitsuo Namiki has worked with various organizations, including Sumitomo Pharmaceuticals Co., Ltd. His innovative approaches have garnered attention in the medical community, contributing to advancements in treatment methodologies.
Collaborations
Namiki has collaborated with notable individuals in his field, including Toshikazu Nakamura and Akira Shiota. These partnerships have played a crucial role in the development of his patents and the advancement of medical treatments.
Conclusion
Mitsuo Namiki's contributions to the treatment of fibrosis through innovative methods highlight his importance as an inventor in the medical field. His work continues to influence the development of effective therapies for patients suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile